Print this page
 Email this page

 Connect with UMGCC on:
 Twitter
 Facebook
 YouTube

 Share this page:

Bookmark and Share

Hematologic Malignancies Program

UMGCC Named Center of Excellence by Myelodysplastic Syndromes Foundation
 

Ask the Expert

Dr. Baer’s Bio Image

Get answers to your Myelodysplastic Syndromes questions.

Dr. Baer’s Bio | Q&A Archive

Note: This is for informational purposes only. Doctors cannot provide a diagnosis or individual treatment advice via e-mail. Please consult your physician about your specific health care concerns.

Video details

[ Flash player icon ] Please install flash player to see this video.

Cancer Center Virtual Tour

Click to take a virtual tour

Related Content


 

The University of Maryland Marlene and Stewart Greenebaum Cancer Center has been designated as a Center of Excellence by the Myelodysplastic Syndromes Foundation.

To be recognized as a Center of Excellence for treatment in myelodysplastic syndromes (MDS), a hospital must have:

For More Information:

  • About Myelodysplastic Syndromes
  • Hematologic Malignancies Program

  • This page was last updated on: October 7, 2009.